Cargando…

Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients

BACKGROUND: There is uncertainty whether low-risk episodes of febrile neutropaenia (FN) in adult cancer patients are best managed in the in- or outpatient setting. METHODS: A Monte Carlo cost–utility model was created to compare four treatment strategies for low-risk FN: (1) treatment in hospital wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teuffel, O, Amir, E, Alibhai, S, Beyene, J, Sung, L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101923/ https://www.ncbi.nlm.nih.gov/pubmed/21468048 http://dx.doi.org/10.1038/bjc.2011.101

Ejemplares similares

Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia
por: Cheng, S, et al.
Publicado: (2011)

1653. Cost effectiveness of Levofloxacin Vs Amoxicillin/Clavulanate And Ciprofloxacin In The Outpatient Management Of Low-Risk Febrile Neutropaenia In Children With Cancer: A Randomised Control Study.
por: Khedr, Reham, et al.
Publicado: (2023)

Aetiology of Bacteraemia as a Risk Factor for Septic Shock at the Onset of Febrile Neutropaenia in Adult Cancer Patients
por: Rosa, Regis Goulart, et al.
Publicado: (2014)

Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis
por: Debled, M, et al.
Publicado: (2007)

Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study
por: Rosa, Regis G, et al.
Publicado: (2014)

Primary prophylaxis with biosimilar filgrastim cost-effective approach to avoid febrile neutropenia
Publicado: (2021)

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020)

A case of chronic disseminated candidiasis in metamizole-induced neutropaenia
por: Colin-Benoit, Eugénie, et al.
Publicado: (2022)

Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients
por: Carmona-Bayonas, A, et al.
Publicado: (2011)

Treatment patterns and outcomes in patients with non‐small cell lung cancer receiving biosimilar filgrastim for prophylaxis of chemotherapy‐induced/febrile neutropaenia: Results from the MONITOR‐GCSF study
por: Aapro, Matti, et al.
Publicado: (2019)

Gaseous liver abscess with Clostridium perfringens sepsis in a patient with neutropaenia
por: Amjad, Waseem, et al.
Publicado: (2019)

Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
por: Shokane, Lucky L., et al.
Publicado: (2023)

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome
por: Fragoulis, George E, et al.
Publicado: (2018)

Mannose-Binding Lectin 2 Polymorphisms Do Not Influence Frequency or Type of Infection in Adults with Chemotherapy Induced Neutropaenia
por: Wong, Michelle, et al.
Publicado: (2012)

Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy
por: Tek, Ibrahim, et al.
Publicado: (2013)

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
por: Harder, J, et al.
Publicado: (2006)

Outpatient treatment costs and their potential impact on cancer care
por: Isshiki, Takahiro
Publicado: (2014)

Childhood febrile illness and the risk of myopia in UK Biobank participants
por: Guggenheim, J A, et al.
Publicado: (2016)

Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
por: Yoshida, Isao, et al.
Publicado: (2020)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Management of febrile neutropenia in the United Kingdom: time for a national trial?
por: Innes, H, et al.
Publicado: (2005)

A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia
por: Fonseca, Paula Jiménez, et al.
Publicado: (2016)

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis
por: Phillips, Robert S, et al.
Publicado: (2016)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis
por: Wailoo, A, et al.
Publicado: (2009)

Outpatient Myelography: A Prospective Trial Comparing Complications after Myelography between Outpatients and Inpatients in Japan
por: Matsumoto, Tomohiro, et al.
Publicado: (2015)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

Cost-Effectiveness of Total Colonoscopy in Screening of Colorectal Cancer in Japan
por: Sekiguchi, Masau, et al.
Publicado: (2012)

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings
por: Okera, M, et al.
Publicado: (2011)

Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials
por: Ethier, M C, et al.
Publicado: (2012)

Validation of the Children's International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT
por: Jacobs, S, et al.
Publicado: (2013)

The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review
por: Williams, S, et al.
Publicado: (2006)

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA
por: Catic, Tarik, et al.
Publicado: (2016)

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
por: Atherly, A J, et al.
Publicado: (2012)

Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment
por: Starling, N, et al.
Publicado: (2007)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
por: Shiroiwa, T, et al.
Publicado: (2009)

Comparison of Two Common Outpatient Preparations for Colonoscopy in Children and Youth
por: Jimenez-Rivera, Carolina, et al.
Publicado: (2009)

Management of adolescents and adults with febrile illness in resource limited areas
por: Crump, John A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_86tj62kksev942uiil2lgthg2g